Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea
· Delayed Price · Currency is KRW 2,385.00
-5.00 (-0.21%)
At close: Mar 28, 2025, 3:30 PM KST
Sewoon Medical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Other Revenue | - | -0 | - | - | -0 | Upgrade
|
| Revenue | 60,151 | 68,247 | 60,116 | 62,579 | 63,729 | Upgrade
|
| Revenue Growth (YoY) | -11.86% | 13.53% | -3.94% | -1.80% | -4.70% | Upgrade
|
| Cost of Revenue | 37,963 | 40,689 | 37,896 | 37,522 | 40,005 | Upgrade
|
| Gross Profit | 22,188 | 27,557 | 22,220 | 25,057 | 23,725 | Upgrade
|
| Selling, General & Admin | 9,468 | 9,330 | 8,734 | 8,466 | 8,344 | Upgrade
|
| Research & Development | 510.42 | 468.21 | 505.09 | 427.87 | 321.38 | Upgrade
|
| Operating Expenses | 10,811 | 10,637 | 10,033 | 9,671 | 9,828 | Upgrade
|
| Operating Income | 11,377 | 16,920 | 12,187 | 15,386 | 13,897 | Upgrade
|
| Interest Expense | -36.63 | -36.08 | -35.81 | -31.47 | -31.63 | Upgrade
|
| Interest & Investment Income | 2,331 | 1,969 | 736.18 | 172.83 | 133.32 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,597 | 357.41 | 702.87 | 1,035 | -578.91 | Upgrade
|
| Other Non Operating Income (Expenses) | 73.35 | 69.67 | 38.25 | 67.05 | 159.15 | Upgrade
|
| EBT Excluding Unusual Items | 15,342 | 19,280 | 13,629 | 16,630 | 13,579 | Upgrade
|
| Gain (Loss) on Sale of Assets | 279.54 | 17.79 | 2.2 | -0.67 | -8.81 | Upgrade
|
| Asset Writedown | - | - | -2 | -2.96 | -233.53 | Upgrade
|
| Pretax Income | 15,621 | 19,298 | 13,629 | 16,626 | 13,337 | Upgrade
|
| Income Tax Expense | 3,046 | 3,824 | 2,990 | 3,864 | 2,782 | Upgrade
|
| Earnings From Continuing Operations | 12,575 | 15,474 | 10,639 | 12,762 | 10,555 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 286.25 | Upgrade
|
| Net Income to Company | 12,575 | 15,474 | 10,639 | 12,762 | 10,841 | Upgrade
|
| Minority Interest in Earnings | -412.61 | -517.02 | -232.69 | -480.5 | -345.26 | Upgrade
|
| Net Income | 12,163 | 14,957 | 10,406 | 12,282 | 10,496 | Upgrade
|
| Net Income to Common | 12,163 | 14,957 | 10,406 | 12,282 | 10,496 | Upgrade
|
| Net Income Growth | -18.68% | 43.73% | -15.27% | 17.02% | 10.76% | Upgrade
|
| Shares Outstanding (Basic) | 43 | 43 | 43 | 43 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 43 | Upgrade
|
| Shares Change (YoY) | -0.16% | 0.14% | - | - | - | Upgrade
|
| EPS (Basic) | 281.00 | 345.00 | 240.38 | 283.70 | 242.44 | Upgrade
|
| EPS (Diluted) | 281.00 | 345.00 | 240.38 | 283.70 | 242.44 | Upgrade
|
| EPS Growth | -18.55% | 43.52% | -15.27% | 17.02% | 10.76% | Upgrade
|
| Free Cash Flow | 11,750 | 21,127 | 7,128 | 19,244 | 16,978 | Upgrade
|
| Free Cash Flow Per Share | 271.47 | 487.32 | 164.65 | 444.53 | 392.19 | Upgrade
|
| Dividend Per Share | - | - | 60.000 | 50.000 | 50.000 | Upgrade
|
| Dividend Growth | - | - | 20.00% | - | - | Upgrade
|
| Gross Margin | 36.89% | 40.38% | 36.96% | 40.04% | 37.23% | Upgrade
|
| Operating Margin | 18.91% | 24.79% | 20.27% | 24.59% | 21.81% | Upgrade
|
| Profit Margin | 20.22% | 21.92% | 17.31% | 19.63% | 16.47% | Upgrade
|
| Free Cash Flow Margin | 19.54% | 30.96% | 11.86% | 30.75% | 26.64% | Upgrade
|
| EBITDA | 14,857 | 20,568 | 16,075 | 19,222 | 17,581 | Upgrade
|
| EBITDA Margin | 24.70% | 30.14% | 26.74% | 30.72% | 27.59% | Upgrade
|
| D&A For EBITDA | 3,480 | 3,648 | 3,888 | 3,836 | 3,684 | Upgrade
|
| EBIT | 11,377 | 16,920 | 12,187 | 15,386 | 13,897 | Upgrade
|
| EBIT Margin | 18.91% | 24.79% | 20.27% | 24.59% | 21.81% | Upgrade
|
| Effective Tax Rate | 19.50% | 19.82% | 21.94% | 23.24% | 20.86% | Upgrade
|
| Advertising Expenses | 294.06 | 233.54 | 186.34 | 76.21 | 29.71 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.